There are 2137 resources available
1415TiP - INSIGHT 2: Tepotinib + osimertinib in patients (pts) with EGFR-mutant NSCLC having acquired resistance to first-line osimertinib due to MET amplification (METamp)
Presenter: Egbert Smit
Session: E-Poster Display
Resources:
Abstract
1416TiP - CodeBreak 200: A phase III multicenter study of sotorasib (AMG 510), a KRAS(G12C) inhibitor, versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC) harboring KRAS p.G12C mutation
Presenter: Martin Reck
Session: E-Poster Display
Resources:
Abstract
1417TiP - Immunotherapy, chemotherapy and stereotactic radiotherapy to metastases, followed by definitive surgery or radiotherapy to the primary tumour, in patients with synchronous oligo-metastatic NSCLC: The ETOP CHESS trial
Presenter: Matthias Guckenberger
Session: E-Poster Display
Resources:
Abstract
1418TiP - Randomized, placebo-controlled phase III study of 1L pembrolizumab (Pembro) plus carboplatin/taxane followed by pembro with or without maintenance olaparib in patients (Pts) with metastatic squamous non-small cell lung cancer (sqNSCLC): KEYLYNK-008
Presenter: Jhanelle E Gray
Session: E-Poster Display
Resources:
Abstract
1419TiP - ARC-7: A phase II study to evaluate the safety and efficacy of zimberelimab alone, AB154 in combination with zimberelimab, and AB154 in combination with zimberelimab and AB928 in front-line, PD-L1 expressing, non-small cell lung cancer (NSCLC)
Presenter: Arvind Chaudhry
Session: E-Poster Display
Resources:
Abstract
1420TiP - A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC)
Presenter: Martin Reck
Session: E-Poster Display
Resources:
Abstract
1426P - Gender differences in treatment characteristics and outcomes of esophagogastric cancer surgery - Data from the Dutch upper-GI cancer audit
Presenter: Marianne Kalff
Session: E-Poster Display
Resources:
Abstract
1427P - A phase II study of neoadjuvant concurrent chemoradiotherapy with apatinib for HER-2 negative Siewert type II and III adenocarcinoma of esophagogastric junction
Presenter: Qun Zhao
Session: E-Poster Display
Resources:
Abstract
1428P - Apatinib combined with docetaxel in second-line treatment of advanced gastric cancer: A prospective clinical study (data updated)
Presenter: Mudan Yang
Session: E-Poster Display
Resources:
Abstract
1429P - Phase II trial of perioperative mdcf + avelumab in locally advanced gastroesophageal adenocarcinoma: Safety/efficacy
Presenter: Thierry Alcindor
Session: E-Poster Display
Resources:
Abstract